Epigenetic biomarkers in skin cancer

被引：48
|
作者：
Greenberg, Edward S. [1 ]
Chong, Kelly K. [1 ]
Huynh, Kelly T. [1 ]
Tanaka, Ryo [1 ]
Hoon, Dave S. B. [1 ]
机构：
[1] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA
来源：
CANCER LETTERS | 2014年 / 342卷 / 02期
基金：
美国国家卫生研究院;
关键词：
Epigenetics; Biomarker; Methylation; MicroRNA; Melanoma; Prognosis; ISLAND METHYLATOR PHENOTYPE; MELANOMA-CELL PROLIFERATION; ABERRANT DNA METHYLATION; TUMOR-SUPPRESSOR GENES; REAL-TIME PCR; DOWN-REGULATION; CUTANEOUS MELANOMA; PROMOTER HYPERMETHYLATION; CIRCULATING MICRORNAS; PERIPHERAL-BLOOD;
D O I：
10.1016/j.canlet.2012.01.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Epigenetic aberrations have been associated with cutaneous melanoma tumorigenesis and progression including dysregulated DNA gene promoter region methylation, histone modification, and microRNA. Several of these major epigenetic aberrations have been developed into biomarkers. Epigenetic biomarkers can be detected in tissue and in blood as circulating DNA in melanoma patients. There is strong evidence that biomarkers in cutaneous melanoma will have an important role as companions to therapeutics and overall patient management. Important progress has been made in epigenetic melanoma biomarker development and verification of clinical utility, and this review discusses some of the key current developments and existing challenges. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：170 / 177
页数：8
相关论文
共 50 条
  • [31] New Progress of Epigenetic Biomarkers in Urological Cancer
    Wu, Peng
    Cao, Ziyi
    Wu, Song
    DISEASE MARKERS, 2016, 2016
  • [32] microRNAs as novel epigenetic biomarkers for human cancer
    Cortes-Sempere, Maria
    Ibanez de Caceres, Inmaculada
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (06): : 357 - 362
  • [33] Epigenetic biomarkers and breast cancer: Cause for optimism
    Visvanathan, Kala
    Sukumar, Saraswati
    Davidson, Nancy E.
    CLINICAL CANCER RESEARCH, 2006, 12 (22) : 6591 - 6593
  • [34] COMMON EPIGENETIC BIOMARKERS IN CHRONIC INFLAMMATION AND CANCER
    Ospelt, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 32 - 32
  • [35] Epigenetic biomarkers in colorectal cancer: premises and prospects
    Zamani, Mozhdeh
    Hosseini, Seyed Vahid
    Mokarram, Pooneh
    BIOMARKERS, 2018, 23 (02) : 105 - 114
  • [36] Epigenetic biomarkers for detection of cancer: State of the science
    Cairns, Paul
    CANCER BIOMARKERS, 2008, 4 (03) : 128 - 128
  • [37] Defining epigenetic biomarkers of aggressive prostate cancer
    Logotheti, S.
    Mesiakaris, K.
    Kontogianni, E.
    Estecio, M.
    Soundararajan, R.
    Shepherd, P.
    Lazaros, K.
    Vrahatis, A.
    Logothetis, C.
    Aparicio, A.
    Tzelepi, V.
    VIRCHOWS ARCHIV, 2024, 485 : S174 - S175
  • [38] Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
    Okugawa, Yoshinaga
    Grady, William M.
    Goel, Ajay
    GASTROENTEROLOGY, 2015, 149 (05) : 1204 - +
  • [39] microRNAs as novel epigenetic biomarkers for human cancer
    María Cortés-Sempere
    Inmaculada Ibáñez de Cáceres
    Clinical and Translational Oncology, 2011, 13 : 357 - 362
  • [40] Epigenetic Biomarkers for the Early Detection of Gastrointestinal Cancer
    Chen, Hui-Min
    Fang, Jing-Yuan
    GASTROINTESTINAL TUMORS, 2015, 1 (04) : 201 - 208
12345